The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

Glenmark is eligible for 180 days of CGT exclusivity upon commercialization of generic FloVent. FloVent HFA Inhalation Aerosol, 44 mcg had a market value of approximately $520.1 million. for the ...

CGT designations are granted to medicines with limited generic competition, and first‑approved applicants are eligible for six months of exclusivity—an incentive aimed at encouraging development of ...

Glenmark Specialty plans to launch the metered-dose inhaler in March 2026. The Food and Drug Administration (FDA) has approved Fluticasone Propionate Inhalation Aerosol USP, 44mcg, the first generic ...

Glenmark Specialty SA received final approval from the US Food and Drug Administration for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. The product has been determined by the ...

(RTTNews) - Glenmark Specialty SA, a subsidiary of Glenmark Pharmaceuticals Ltd. (532296) Wednesday announced that the U.S. FDA has granted final approval for its Fluticasone Propionate Inhalation ...

ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate ...

ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate ...

The FDA has approved a generic form of fluticasone propionate inhalation aerosol (Flovent HFA) as a prophylactic maintenance treatment for asthma, the agency announced on Tuesday. Delivered as a ...

Today, the U.S. Food and Drug Administration approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 micrograms per actuation, for the maintenance treatment of asthma ...